Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In Vivo

Integrase (IN), the HIV-1 enzyme responsible for the integration of the viral genome into the chromosomes of infected cells, is the target of the recently approved antiviral raltegravir (RAL). Despite this drug's activity against viruses resistant to other antiretrovirals, failures of raltegrav...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Delelis, Olivier, Thierry, Sylvain, Subra, Frédéric, Simon, Françoise, Malet, Isabelle, Alloui, Chakib, Sayon, Sophie, Calvez, Vincent, Deprez, Eric, Marcelin, Anne-Geneviève, Tchertanov, Luba, Mouscadet, Jean-François
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2010
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2798554/
https://ncbi.nlm.nih.gov/pubmed/19901095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01075-09
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi